News

The broad spectrum, oral nucleotide analog lipid-conjugate, CMX001, works by blocking the replication of double-stranded DNA (dsDNA) viruses. The company previously completed Phase II clinical development of CMX001

NC-stat DPNCheck is a quantitative point-of-care test used to detect diabetic neuropathy at an early stage. Handok expects to use both direct and indirect sales channels to promote

The company has submitted a biologics license application (BLA) to the US regulatory body based on the data from registrational Phase III hemophilia A study called A-LONG. Biogen

The firm is mulling to relocate some of the 60 staffers currently working at the site in Cambridge to Philadelphia office. GlaxoSmithKline’s spokesperson Melinda Stubbee was quoted by

The new center, which will see an investment of £20m, will include two floors and occupies 6,257m² space. The building is scheduled to be completed by late 2014

Arestvyr (Tecovirimat) is developed as a therapeutic against smallpox resulting from a terrorist attack, biowarfare or a new natural outbreak and is not yet cleared by the US

The approvals will enable DCVax-L to be produced in Germany and supplied across borders to the UK for the clinical trials. The latest approvals for cross-border supply of

As per the collaboration, API will invest in Neuland’s facilities to meet the needs of its customers. The facilities will be operated by Neuland employees and the two

Participating laboratories engaged in the continual improvement of their BCR-ABL1 testing performance via IS standardization have been recruited in five countries in Europe. The study will evaluate the